
Tumor PDO 2.0
An ALI-based tumor model for studying treatment response alongside source-tissue architecture and immune cells retained from the sample.
Models & products
Explore tumor PDOs, normal-tissue organoids and disease models. Find models and assays that fit your study.
Start from a common study combination or select up to three models.
Choosing PDO 1.0 or PDO 2.0Featured models · use the filters to explore the full portfolio
0 of 3 models selected for comparison

An ALI-based tumor model for studying treatment response alongside source-tissue architecture and immune cells retained from the sample.

Assess drug-related kidney injury through morphology, nephron markers and molecular readouts, with culture conditions matched to your candidate.

Human lung organoids for pulmonary-injury and candidate studies, combining airway and alveolar cell profiling with changes in tissue morphology.

Organoids from adjacent non-tumor liver tissue for epithelial-biology, drug-exposure and tumor-versus-adjacent-tissue studies.

Study gastric epithelial biology and drug exposure in normal human organoids, with imaging of tissue structure, proliferation and mucin-related markers.

Profile human endometrial organoids across proliferative, secretory and receptive stages through serial culture imaging and epithelial markers.

Human fallopian tube organoids with serial culture morphology and source-tissue/organoid H&E comparison, plus study-specific identity and functional assays.

Study IBD-like inflammation in human intestinal organoids through morphology, FITC-Dextran, IL-8 and image-based candidate readouts.

Patient-derived breast tumor organoids for single-agent and combination studies, with PDO 2.0 / ALI considered when immune context is relevant.
Explore disease and barrier models, filter by organ, study goal or collaboration format, or discuss a tailored program for specialized tissues and functional endpoints.
PRODUCT CATALOG

A starter kit for PDO 2.0 / ALI recovery and initial culture, with protocol guidance and technical support.

Core reagents for teams with ALI experience or preparing to establish a routine PDO 2.0 culture workflow.

Reagents and guidance for primary sample processing, organoid establishment, expansion and gentle passaging.

Configured around model type, cryopreservation scale and post-thaw QC for organoid storage, recovery and biobanking.

For TME-associated cell profiling by flow cytometry or immunofluorescence, with antibody panels matched to the model and assay platform.